As life sciences professionals, we continue to monitor the COVID-19 pandemic, and we firmly support the difficult, but necessary, changes to our daily lives caused by this pandemic.

While this pandemic is difficult for everyone, we are fortunate in that we have been working within our unique distributed consulting model and virtual infrastructure for over ten years now. We are accustomed to operating remotely, working from home, and regularly collaborating with other scientists on complex projects across the country and throughout the world. That’s what we do.

This remote-operating experience, combined with our expertise in advanced analytics, epidemiology, pharmaceutical development and FDA-facing regulatory challenges uniquely positions us to be able to help organizations that have been forced to lay off, reassign and/or furlough key scientists and put important life-sciences projects on hold.

We want you to know that we are fully staffed, with no layoffs to date or planned, and we are ready, willing and able to help any of our existing clients whose important projects have been slowed by the impact of COVID-19. We also have some capacity to take on a few new projects.

Please feel free to reach out to us if we can help you, even in an interim role. But most importantly, please heed the government guidelines to minimize your exposure to COVID-19 and stay safe. Together, we will get through this.